- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02410707
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults, a Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This pilot study will be conducted in a prospective, non-randomized fashion using a convenience sample of 100 subjects undergoing sedation for Emergency Department procedures.
Recruitment Methods The research associates as well as the health care team (both residents and attending physicians) will screen patients who may need procedural sedation in the Emergency Department and may qualify for the study. Research associates will use the Medical Record
Procedures Involved in the Research Initial medical assessment will be made in accordance with established clinical procedures, including the history, physical examination, and vital signs. If by clinical assessment the patient meets eligibility criteria, then they will be approached by a research associate for enrollment in the study. After informed consent is obtained and prior to starting the sedation, standard vital sign monitoring will be placed on the patient (electrocardiogram, non-invasive blood pressure monitoring, pulse oximetry, and capnography). Level of consciousness will be determined using the modified Ramsay scale, which will be assessed at baseline. The Entitled Carbon Di Oxide (CO2) monitor will be used as the primary device to measure Entitled Carbon Di Oxide (CO2), with a nasal cannula capable of delivering supplemental oxygen and measuring Entitled CO2.
The Nitrous Oxide gas mixer system will be used as the primary nitrous oxide delivery device. It will mix and deliver nitrous oxide and oxygen in a 1:1 ratio, at a fixed concentration of 50%/50%. It uses a patient driven demand valve system that is hand held. This device provides a consistent, fixed 50%/50% blend of nitrous oxide (N2O) and oxygen (O2), eliminates the need to titrate, and provides fixed concentrations for controlled and consistent dosing. The device comparator detects dosing imbalance to protect against hypoxic mixtures, it cannot deliver nitrous gas without concurrent oxygen, and the device has an anti-asphyxia valve override. The on demand valve requires patient inspiration to trigger dosing. This portable device scavenges exhaled waste gases for environmental safety, as well as a key mechanism that renders the system inoperable without it for security.
After informed consent, the patient will fill out a pre procedure questionnaire and a 100 mm VAS baseline pain scale. The patient will be given the mask for delivery of nitrous oxide, and instructed on its use. The research associate will mark the time the patient began using the device electronically. Once IV access is established, and the team and patient are ready to begin the procedure, the nitrous oxide mask will be removed, and a 100% non rebreather mask delivering 15 liters a minute of supplemental oxygen will be placed on the patients face. The loading dose of propofol will then be administered immediately. All sedations in this trial will use propofol 1.0 mg/Kg initial dose, with 0.5 mg/Kg doses titrated to deep sedation. Once the patient is deeply sedated, the procedure will begin.
The subject's clinical data and sedation information (refer to data management) will be entered into a standardized data collection form. The data will be continuously recorded throughout the sedation and recovery periods. Study will end when the subjects recovers back to baseline mental status.
Vital signs will be flagged electronically when a physician intervenes for clinical respiratory depression. Respiratory depression will be defined as peripheral Oxygen saturation below 92%, Entitled CO2 level above 50, a rise or decrease of 10% above or below baseline, the loss of the Entitled CO2 waveform for more than 15 seconds. Level of consciousness will be determined using the modified Ramsay scale, which will be recorded at baseline and at the point of deepest sedation. Once the procedure is complete, and the patient is deemed back to their mental status baseline, they will fill out a post procedure satisfaction questionnaire, and a 100 mm VAS scale. They will be asked about procedure recall. The physician and nurse involved will also fill out a post procedure questionnaire.
System for screening, and they will be in charge of informed consent, enrollment, placement of the capnography monitor, as well as data collection. The health care team will be in charge of the procedural sedation and all other management.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19141
- Albert Einstein Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Spontaneous respirations
- 18 years of age and older
- American Society of Anesthesiologists (ASA) Physical Status Classification 1 or 2, who will be receiving sedation for an Emergency Department procedure.
- Ability to provide informed consent.
Exclusion Criteria:
- Comorbidities that affect ventilation, perfusion, or metabolism
- Intubated
- Cardiopulmonary instability
- Major trauma
- Sepsis
- American Society of Anesthesiologists (ASA) class 3, 4, and 5.
- Inability to provide informed consent
- Nursing home residents
- Age less than 18 years
- Non English speaking
- Pregnant women
- Under police custody
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nitrous Oxide Arm
Patients undergoing procedural sedation with propofol will undergo an initial medical assessment including the history, physical examination, and vital signs.
The patients will then receive Nitrous Oxide gas via a gas mixer device before receiving propofol.
The device will mix and deliver nitrous oxide and oxygen in a 1:1 ratio, at a fixed concentration of 50%/50%.
The on demand valve requires patient inspiration to trigger dosing.
|
Patients undergoing procedural sedation with propofol will undergo an initial medical assessment including the history, physical examination, and vital signs.
The patients will then receive Nitrous Oxide gas via a gas mixer device before receiving propofol.
The device will mix and deliver nitrous oxide and oxygen in a 1:1 ratio, at a fixed concentration of 50%/50%.
The on demand valve requires patient inspiration to trigger dosing.
Other Names:
The loading dose of propofol will be administered immediately after nitrous oxide discontinuation.
All sedations in this trial will use propofol 1.0 mg/Kg initial dose, with 0.5 mg/Kg doses titrated to deep sedation.
Once the patient is deeply sedated, the procedure will begin.
Other Names:
If pulse oximetry declines to less than 92%, subject will be placed on nasal cannula with administration of 2 liter flow of oxygen and titrated in increments of 1 L flow to maintain pulse oximetry greater than 92%
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Number of Respiratory Depression Events
Time Frame: day 1
|
End tidal CO2 and SpO2 measured every 20 milliseconds seconds captured by a monitoring device.
Events of respiratory depression are defined as peripheral SaO2 below 92%, ETCO2 level above 50, a rise or decrease of 10% above or below baseline, and/or the loss of the ETCO2 waveform for more than 15 seconds
|
day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Number of Airway Repositioning Events
Time Frame: day 1
|
Presence or absence of physician intervention requiring airway repositioning by provider due to decreased oxygen saturation less than 92%
|
day 1
|
Total Number of Events Requiring Additional Oxygen
Time Frame: day 1
|
Presence or absence of physician intervention requiring additional oxygen via nasal cannula or non rebreather by the provider due to oxygen saturation less than 92%
|
day 1
|
Total Number of Positive Pressure Ventilation Events
Time Frame: day 1
|
Presence or absence of physician intervention requiring positive pressure ventilation via a bag valve max due to decreased oxygen saturation less than 92%
|
day 1
|
Total Number of Endotracheal Intubation Events
Time Frame: day 1
|
Presence or absence of physician intervention requiring endotracheal intubation by provider due to decreased oxygen saturation less than 92%
|
day 1
|
Total Number of Physical Stimulation Events
Time Frame: day 1
|
Presence or absence of physician intervention requiring physical stimulation by the provider due to decreased oxygen saturation less than 92%
|
day 1
|
Patient, Physician, and Nurse Satisfaction Surveys
Time Frame: day 1
|
Patient satisfaction with use of Nitrous Oxide in anxiolysis and pain control
|
day 1
|
Post-Procedure VAS Pain Score
Time Frame: day 1
|
Visual Analog Scale (0-100mm), where 0 mm is minimum pain, and 100 mm is maximum pain.
|
day 1
|
Collaborators and Investigators
Investigators
- Principal Investigator: Joseph Herres, DO, Albert Einstein Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Inflammation
- Wounds and Injuries
- Disease Attributes
- Joint Diseases
- Musculoskeletal Diseases
- Suppuration
- Emergencies
- Abscess
- Joint Dislocations
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Non-Narcotic
- Hypnotics and Sedatives
- Anesthetics, Inhalation
- Propofol
- Nitrous Oxide
Other Study ID Numbers
- HN4641
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abscess
-
Hospital Italiano de Buenos AiresUnknownLiver Transplant AbscessArgentina
-
Inje UniversityPusan National University Yangsan HospitalCompletedCryptogenic Pyogenic Liver AbscessKorea, Republic of
-
Kaohsiung Veterans General Hospital.BayerCompletedLiver AbscessTaiwan
-
Manchester University NHS Foundation TrustUniversity of Liverpool; University of Birmingham; National Institute for Health... and other collaboratorsCompletedPerianal Abscess | Perianal Infections | Peri Rectal Abscess | Abscess; Anus | Abscess AnorectalUnited Kingdom
-
Northwell HealthPediatric Surgical Research CollaborativeActive, not recruitingPilonidal Disease | Pilonidal Sinus Without Abscess | Pilonidal Cyst/Fistula | Pilonidal Cyst Without Abscess | Pilonidal Cyst and Sinus Without Abscess | Pilonidal Abscess | Pilonidal Sinus With Abscess | Pilonidal Dimple With Abscess | Pilonidal Fistula With Abscess | Pilonidal Sinus Infected | Pilonidal... and other conditionsUnited States
-
Kaiser PermanenteGenentech, Inc.CompletedAbdominal Abscess | Pelvic AbscessUnited States
-
Nanfang Hospital of Southern Medical UniversityRecruitingInfections | Abscess | Liver Abscess | Liver Abscess, PyogenicChina
-
Dow University of Health SciencesCompleted
-
The Hospital for Sick ChildrenTerminated
-
Hannover Medical SchoolBayerCompletedAbscess, Intra-AbdominalGermany
Clinical Trials on Nitrous Oxide arm
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
State University of New York at BuffaloCompleted
-
Washington University School of MedicineBrain & Behavior Research FoundationCompletedDepressive Disorder, Major | Depressive Disorder, Treatment-ResistantUnited States
-
Beth Israel Deaconess Medical CenterRecruitingProcedural Pain | Pain Catastrophizing | Procedural AnxietyUnited States
-
Beth Israel Deaconess Medical CenterBoston Children's HospitalCompletedLower Urinary Tract SymptomsUnited States
-
Beth Israel Deaconess Medical CenterBrigham and Women's HospitalCompletedPain | Benign Prostatic Hyperplasia | Prostate Cancer | Prostate Adenocarcinoma | Anxiety and Fear | Malignancy | Prostate DiseaseUnited States
-
Washington University School of MedicineFoundation for Anesthesia Education and ResearchCompletedCardiovascular AbnormalitiesUnited States
-
National Institute of Diabetes and Digestive and...CompletedAvitaminosis | Delirium, Dementia, Amnestic, Cognitive DisordersUnited States
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
Baxter Healthcare CorporationCompleted